Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Rekor Systems | REKR | Oct 30, 2024 | 1.06 | -5.36 |
Relay Therapeutics | RLAY | Oct 30, 2024 | 5.71 | -3.22 |
Reliance | RS | Oct 30, 2024 | 289.59 | -1.62 |
Reliance Global | RELI | Oct 30, 2024 | 2.31 | -2.12 |
Relmada Therapeutics | RLMD | Oct 30, 2024 | 3.50 | -1.96 |
RELX ADR | RELX | Oct 30, 2024 | 46.91 | -2.09 |
Remitly Global | RELY | Oct 30, 2024 | 15.26 | +2.35 |
Renaissance Ipo ETF | IPO | Oct 30, 2024 | 45.37 | +0.05 |
RenaissanceRe | RNR | Oct 30, 2024 | 267.40 | -0.25 |
RenaissanceRe G Pref | RNR-G | Oct 30, 2024 | 18.38 | +0.49 |
RenaissanceRe Holding F Pref | RNR-F | Oct 30, 2024 | 24.24 | +0.25 |
Renalytix ADR | RNLX | Oct 30, 2024 | 0.20 | 0.00 |
Renasant | RNST | Oct 30, 2024 | 34.65 | +0.49 |
Reneo Pharmaceuticals | RPHM | Oct 30, 2024 | 1.82 | 0.00 |
ReNew Energy Global A Shares | RNW | Oct 30, 2024 | 5.84 | +1.57 |
Renn Fund | RCG | Oct 30, 2024 | 2.20 | +1.62 |
Renovaro Biosciences | RENB | Oct 30, 2024 | 0.54 | +5.57 |
RenovoRx | RNXT | Oct 30, 2024 | 1.00 | -3.32 |
Rent The Runway A | RENT | Oct 30, 2024 | 9.98 | -2.06 |
Rentokil Initial ADR | RTO | Oct 30, 2024 | 25.18 | -1.45 |
Repare Therapeutics | RPTX | Oct 30, 2024 | 3.45 | -3.90 |
Repay A | RPAY | Oct 30, 2024 | 8.00 | +4.58 |
Repligen | RGEN | Oct 30, 2024 | 136.38 | +1.12 |
Replimune Group | REPL | Oct 30, 2024 | 12.11 | -1.38 |
ReposiTrak | TRAK | Oct 30, 2024 | 19.65 | +2.45 |
Republic Bancorp A | RBCAA | Oct 30, 2024 | 68.89 | +0.19 |
Republic Services | RSG | Oct 30, 2024 | 198.81 | -2.69 |
Research Frontiers | REFR | Oct 30, 2024 | 2.16 | -2.26 |
Research Solutions | RSSS | Oct 30, 2024 | 2.62 | -3.32 |
Reservoir Media | RSVR | Oct 30, 2024 | 8.66 | -1.48 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.